Speeding Drug Development Through Impurity

Dr. Steven Baertschi delivered this talk in South San Francisco, CA on October 31, 2018.

Biopharmaceutical researchers and scientists are continuously working to develop new and innovative

Discovering and bringing one new

In Chapter 2 of our “AI at Sanofi” series, we explore how #AI is accelerating our efforts to bring breakthrough

A talk by George D. Demetri, MD, director, Ludwig Center at Dana-Farber/Harvard; associate professor of

Regis' Director of Analytical Method

How much of a

The biology of the human body is complex;

Understanding

Unexpected peaks in your chromatogram? That could be an unknown

Regis' Director of Analytical Method

The

The National Institute of Allergy and Infectious Diseases explains the

On September 2, 2020, FDA published a guidance for industry entitled Control of Nitrosamine

FDA discusses the OGD-Pharmacology/Toxicology (Pharm/Tox) process for safety evaluation of

David Li, Co-Founder and CEO of Meliora Therapeutics, sits down with Neil to discuss why the mechanism of action for cancer ...

The current process of

MIT Sloan Professor Andrew Lo goes

Impurity

If necessity is indeed the mother of invention, then our current